Skip to content
10-Q

Quarterly Report

ONCOVISTA INNOVATIVE THERAPIES, INC

0001144204-14-067419

← back to feed
Filed
Nov 13, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Nov 12, 2014 21.63M sh
Short Term Debt Q3 2014 · Sep 30, 2014 $200K
Stockholders Equity Q3 2014 · Sep 30, 2014 −$4.09M
Stockholders Equity Q3 2014 · Dec 31, 2013 −$3.12M
Current Liabilities Q3 2014 · Sep 30, 2014 $4.21M
Current Liabilities Q3 2014 · Dec 31, 2013 $3.22M
Current Assets Q3 2014 · Sep 30, 2014 $119.23K
Current Assets Q3 2014 · Dec 31, 2013 $95.84K
Total Assets Q3 2014 · Sep 30, 2014 $119.23K
Total Assets Q3 2014 · Dec 31, 2013 $96.32K
Cash And Equivalents Q3 2014 · Sep 30, 2013 $75.19K
Cash And Equivalents Q3 2014 · Dec 31, 2012 $511.69K
Sga Expense Q3 2014 · Sep 30, 2013 $117.36K
Sga Expense Q3 2014 · Sep 30, 2013 $409.9K
Rd Expense Q3 2014 · Sep 30, 2013 $222.16K
Rd Expense Q3 2014 · Sep 30, 2013 $675.69K
Net Income Q3 2014 · Sep 30, 2013 −$368.67K
Net Income Q3 2014 · Sep 30, 2013 −$1.07M
Operating Income Q3 2014 · Sep 30, 2013 −$339.52K
Operating Income Q3 2014 · Sep 30, 2013 −$1.09M
Revenue Q3 2014 · Sep 30, 2013 $0
Revenue Q3 2014 · Sep 30, 2013 $0